ANAB - AnaptysBio - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ANAB is currently covered by 7 analysts with an average price target of $68.74. This is a potential upside of $24.07 (53.88%) from yesterday's end of day stock price of $44.67.

AnaptysBio's activity chart (see below) currently has 149 price targets and 122 ratings on display. The stock rating distribution of ANAB is 23.53% HOLD and 76.47% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 54.52% with an average time for these price targets to be met of 390.56 days.

Highest price target for ANAB is $90, Lowest price target is $51, average price target is $73.5.

Most recent stock forecast was given by ELIANA MERLE from UBS on 07-Jan-2026. First documented stock forecast 21-Feb-2017.

Currently out of the existing stock ratings of ANAB, 4 are a HOLD (23.53%), 13 are a BUY (76.47%).

Analyst name

Rating

Rating initiation date

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

Since 07-Jan-2026

$70

$25.33 (56.70%)

$20

4 days ago
(07-Jan-2026)

7/13 (53.85%)

$26.09 (59.42%)

129

Buy

Since 04-Jun-2025

$51

$6.33 (14.17%)

$52

1 months 18 days ago
(24-Nov-2025)

4/12 (33.33%)

$9.05 (21.57%)

72

Buy

Since 21-Feb-2024

$80

$35.33 (79.09%)

$55

2 months 13 days ago
(29-Oct-2025)

1/3 (33.33%)

$43.88 (121.48%)

670

Buy

Since 10-May-2024

$70

$25.33 (56.70%)

$40

2 months 27 days ago
(15-Oct-2025)

13/19 (68.42%)

$35.74 (104.32%)

147

Buy

Since 19-Jul-2024

$80

$35.33 (79.09%)

$42

5 months 18 days ago
(24-Jul-2025)

9/14 (64.29%)

$53.01 (196.41%)

488

Show more analysts

Please expand the browser size to see the chart

What is ANAB (AnaptysBio) average time for price targets to be met?

On average it took 390.56 days on average for the stock forecasts to be realized with a an average price target met ratio 54.52

Which analyst has the current highest performing score on ANAB (AnaptysBio) with a proven track record?

YATIN SUNEJA

Which analyst has the most public recommendations on ANAB (AnaptysBio)?

Yatin Suneja works at GUGGENHEIM and has 9 price targets and 5 ratings on ANAB

Which analyst is the currently most bullish on ANAB (AnaptysBio)?

Konstantinos Aprilakis with highest potential upside - $108.33

Which analyst is the currently most reserved on ANAB (AnaptysBio)?

Biren Amin with lowest potential downside - -$32.67

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?